ImmuCell Corporation (ICCC) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    ImmuCell Corporation

    NASDAQ: ICCC · Real-Time Price · USD
    6.22
    0.06 (0.97%)
    At close: Sep 10, 2025, 3:59 PM
    6.15
    -1.13%
    After-hours: Sep 10, 2025, 04:04 PM EDT

    ImmuCell Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 3.76M 978.74K 5.79M 10.19M
    Short-Term Investments
    		 n/a n/a n/a -468
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 33.37K 57.66K 76.63K 26.11K
    Receivables
    		 3.81M 2.19M 1.8M 2.72M
    Inventory
    		 7.11M 7.81M 6.04M 3.09M
    Other Current Assets
    		 n/a 39.73K n/a n/a
    Total Current Assets
    		 15.04M 11.47M 13.99M 16.26M
    Property-Plant & Equipment
    		 29.91M 32.15M 30.64M 28M
    Goodwill & Intangibles
    		 114.66K 133.76K 152.87K 171.97K
    Total Long-Term Assets
    		 30.06M 32.34M 30.87M 28.2M
    Total Assets
    		 45.1M 43.81M 44.86M 44.47M
    Account Payables
    		 943.64K 887.73K 790K 745.04K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 1.5M 1.43M 1.04M 812.21K
    Other Current Liabilities
    		 n/a 306.78K n/a n/a
    Total Current Liabilities
    		 4.41M 4.2M 3.07M 2.53M
    Long-Term Debt
    		 9.04M 10.54M 9.19M 8.33M
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 13.17M 14.62M 11.41M 9.35M
    Total Liabilities
    		 17.58M 18.82M 14.48M 11.89M
    Total Debt
    		 15.1M 16.69M 12.48M 10.27M
    Common Stock
    		 904.24K 781.42K 781.42K 781.42K
    Retained Earnings
    		 -14.16M -12.01M -6.23M -3.74M
    Comprehensive Income
    		 n/a -0.00 -0.00 -0.00
    Shareholders Equity
    		 27.52M 24.99M 30.38M 32.58M
    Total Investments
    		 n/a n/a n/a -468

    Add to Watchlist